[HTML][HTML] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - Drug discovery today, 2015 - Elsevier
Highlights•Non-antibody scaffold drugs are a promising new class of biologics drugs.•The
first candidate scaffolds are now moving into clinical development and practice.•Challenges …

Challenges and opportunities for non-antibody scaffold drugs.

R Vazquez-Lombardi, TG Phan… - Drug Discovery …, 2015 - europepmc.org
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan… - Drug discovery …, 2015 - pubmed.ncbi.nlm.nih.gov
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

[PDF][PDF] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - Drug Discovery …, 2015 - core.ac.uk
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

[PDF][PDF] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - researchgate.net
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

[引用][C] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - Drug Discovery …, 2015 - cir.nii.ac.jp
Challenges and opportunities for non-antibody scaffold drugs | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

[PDF][PDF] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - Drug Discovery …, 2015 - csmres.co.uk
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

[PDF][PDF] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan… - Drug Discovery …, 2015 - scholar.archive.org
The first candidates from the promising class of small non-antibody protein scaffolds are now
moving into clinical development and practice. Challenges remain, and scaffolds will need …

[引用][C] Challenges and opportunities for non-antibody scaffold drugs

R Vazquez-Lombardi, TG Phan, C Zimmermann… - Drug Discovery …, 2015 - infona.pl
• Non-antibody scaffold drugs are a promising new class of biologics drugs.• The first
candidate scaffolds are now moving into clinical development and practice.• Challenges …